0001415889-24-005088.txt : 20240223
0001415889-24-005088.hdr.sgml : 20240223
20240223172737
ACCESSION NUMBER: 0001415889-24-005088
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240221
FILED AS OF DATE: 20240223
DATE AS OF CHANGE: 20240223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ford Robert B
CENTRAL INDEX KEY: 0001612571
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-02189
FILM NUMBER: 24672753
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
STREET 2: AP6A-2, D-032L
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-6092
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABBOTT LABORATORIES
CENTRAL INDEX KEY: 0000001800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 360698440
STATE OF INCORPORATION: IL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
BUSINESS PHONE: 2246676100
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
4
1
form4-02232024_100230.xml
X0508
4
2024-02-21
0000001800
ABBOTT LABORATORIES
ABT
0001612571
Ford Robert B
100 ABBOTT PARK ROAD
ABBOTT PARK
IL
60064
true
true
false
false
CHAIRMAN AND CEO
0
Common shares without par value
2024-02-21
4
A
0
70332
0
A
251669
D
Common shares without par value
197403
I
Ford Family Trust
Option (right to buy)
116.98
2024-02-21
4
A
0
264293
0
A
2025-02-21
2034-02-20
Common Shares
264293
264293
D
These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
Held in the Ford Family Trust DTD June 2, 2014. The reporting person is co-trustee of the trust.
Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 88,097 on February 21, 2025, 88,098 on February 21, 2026, and 88,098 on February 21, 2027.
/s/ Robert B. Ford by Jessica H. Paik, Attorney-in-Fact
2024-02-23